[Federal Register Volume 62, Number 114 (Friday, June 13, 1997)]
[Notices]
[Page 32373]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-15455]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on April 16, 1997, Penick 
Corporation, 158 Mount Olivet Avenue, Newark, New Jersey 07114, made 
application by renewal to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule         
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)................  I                         
Dihydromorphine (9145)......................  I                         
Pholcodine (9314)...........................  I                         
Cocaine (9041)..............................  II                        
Codeine (9050)..............................  II                        
Dihydrocodeine (9120).......................  II                        
Oxycodone (9143)............................  II                        
Hydromorphone (9150)........................  II                        
Diphenoxylate (9170)........................  II                        
Benzoylecgonine (9180)......................  II                        
Hydrocodone (9193)..........................  II                        
Meperidine (9230)...........................  II                        
Methadone (9250)............................  II                        
Methadone-intermediate (9254)...............  II                        
Dextropropoxyphene, bulk (non-dosage forms)   II                        
 (9273).                                                                
Morphine (9300).............................  II                        
Thebaine (9333).............................  II                        
Opium extracts (9610).......................  II                        
Opium fluid extract (9620)..................  II                        
Opium tincture (9630).......................  II                        
Opium powdered (9639).......................  II                        
Opium granulated (9640).....................  II                        
Levo-alphacetylmethadol (9648)..............  II                        
Oxymorphone (9652)..........................  II                        
Alfentanil (9737)...........................  II                        
Sufentanil (9740)...........................  II                        
Fentanyl (9801).............................  II                        
------------------------------------------------------------------------

    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Acting Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, United States Department of 
Justice, Washington, D.C. 20537, Attention: DEA Federal Register 
Representative (CCR), and must be filed no later than August 12, 1997.

    Dated: May 7, 1997.
Terrance W. Woodworth,
Acting Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration.
[FR Doc. 97-15455 Filed 6-12-97; 8:45 am]
BILLING CODE 4410-09-M